New research shows that genetic tests can now help predict which heart patients need higher doses of a common anti-clotting drug. Jessica Mega, HMS assistant professor of medicine at Brigham and Women’s Hospital, is the author of the study. Christopher Cannon, HMS associate professor of medicine at Brigham and Women’s Hospital, is also quoted.
